Is there such a thing as a 'lope' dope? Analysis of loperamide-related European Medicines Agency (EMA) pharmacovigilance database reports
Open accessThe DOI matches its Crossref record; 50 of the 52 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Among over-the-counter (OTC) drugs, loperamide has recently emerged for its potential of misuse and cardiotoxicity issues. Hence, we aimed here at assessing the loperamide-related cases being reported to the EMA's EudraVigilance (EV) database. METHODS: All spontaneous EV reports relating to loperamide misuse/abuse/dependence/withdrawal and cardiotoxicity issues were here retrieved, performing a descriptive analysis. FINDINGS: During the years 2005-2017, EV collected a number of 1,983 (out of a total of 7,895; 25.11%) loperamide-related misuse/abuse/dependence/withdrawal adverse drug reaction (ADR) reports, with a progressively increasing trend since 2014. Most cases were classified as drug use disorder (37.4%) or intentional overdose (25.4%). Loperamide was used on its own in 41.9% of cases; remaining, polydrug, cases included antidepressants; benzodiazepines; and other OTCs. Some 1,085 (1,085/7,895 = 13.7%) cardiovascular ADRs were reported, being conduction abnormalities and EKG alterations the most frequently identified. CONCLUSIONS: EV data may support the levels of concern relating to loperamide potential of abuse and associated cardiotoxicity issues.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Its extended-release (XR) formulation may be less frequently misused and abused, due to the delayed (by approximately 3 h) and blunted (by approximately 67%) serum peak; the tablet coating may also make snorting of the crushed tablets quite problematic (47).”
From Coming Off Prescribed Psychotropic Medications: Insights from Their Use as Recreational Drugs (2020) · cites this paper as [47]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
P-glycoprotein Inhibition for Optimal Drug Delivery
Amin, M. L. (2013) · Drug Target Insights · doi:10.4137/dti.s12519 · Cited by 624
Herbal Modulation of P‐Glycoprotein
Zhou, S., Lim, L. Y., & Chowbay, B. (2004) · Drug Metabolism Reviews · doi:10.1081/dmr-120028427 · Cited by 375
Loperamide: a pharmacological review.
Baker, D. E. (2007) · PubMed · Cited by 242
Over-the-counter medicine abuse – a review of the literature
Cooper, R. J. (2013) · Journal of Substance Use · doi:10.3109/14659891.2011.615002 · Cited by 241
Manchikanti, L. (2006) · PubMed · Cited by 186
Dextromethorphan: An update on its utility for neurological and neuropsychiatric disorders
Nguyen, L., Thomas, K. L., Lucke-Wold, B. P., Cavendish, J. Z., Crowe, M. S., & Matsumoto, R. R. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.01.016 · Cited by 141
Daniulaityte, R., Carlson, R. G., Falck, R. S., Cameron, D., Perera, S., Chen, L., & Sheth, A. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.11.003 · Cited by 136
Clinical Review: Loperamide Toxicity
Wu, P. E., & Juurlink, D. N. (2017) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2017.04.008 · Cited by 127
‘Pharming’: the abuse of prescription and over-the-counter drugs in teens
Levine, D. A. (2007) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e32814b09cf · Cited by 101
Loperamide Abuse Associated With Cardiac Dysrhythmia and Death
Eggleston, W. D., Clark, K., & Marraffa, J. M. (2016) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2016.03.047 · Cited by 101
Cardiac conduction disturbance after loperamide abuse
Marraffa, J. M., HOLLAND, M. G., Sullivan, R. W., Morgan, B., Oakes, J. A., Wiegand, T. J., & Hodgman, M. J. (2014) · Clinical Toxicology · doi:10.3109/15563650.2014.969371 · Cited by 99
Nozaki‐Taguchi, N., & Yaksh, T. L. (1999) · Anesthesiology · doi:10.1097/00000542-199901000-00029 · Cited by 92
Jaffe, J. H., Kanzler, M., & Green, J. (1980) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1980.239 · Cited by 74
Kang, J., Compton, D. M., Vaz, R. J., & Rampe, D. (2016) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-016-1286-7 · Cited by 68
Epidemiologic Trends in Loperamide Abuse and Misuse
Vakkalanka, J. P., Charlton, N. P., & Holstege, C. P. (2016) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2016.08.444 · Cited by 62
The Long QT Teaser: Loperamide Abuse
Enakpene, E. O., Riaz, I. B., Shirazi, F. “., Raz, Y., & Indik, J. H. (2015) · The American Journal of Medicine · doi:10.1016/j.amjmed.2015.05.019 · Cited by 55
Swank, K. A., Wu, E., Kortepeter, C. M., McAninch, J., & Levin, R. L. (2017) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2016.11.011 · Cited by 55
Miller, H. I., Panahi, L., Tapia, D., Tran, A., & Bowman, J. D. (2017) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2016.12.079 · Cited by 55
Church, J., Fletcher, E. J., Abdel‐Hamid, K., & MacDonald, J. F. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10162-4 · Cited by 51
Loperamide-Related Deaths in North Carolina
Bishop-Freeman, S. C., Feaster, M. S., Beal, J., Miller, A., Hargrove, R. L., Brower, J. O., & Winecker, R. E. (2016) · Journal of Analytical Toxicology · doi:10.1093/jat/bkw069 · Cited by 51
Loperamide Trends in Abuse and Misuse Over 13 Years: 2002–2015
Lasoff, D. R., Koh, C., Corbett, B. M., Minns, A. B., & Cantrell, F. L. (2016) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1885 · Cited by 50
Loperamide toxicokinetics: serum concentrations in the overdose setting
Eggleston, W. D., Nacca, N. E., & Marraffa, J. M. (2015) · Clinical Toxicology · doi:10.3109/15563650.2015.1026971 · Cited by 49
Karami, S., Major, J. M., Calderon, S. N., & McAninch, J. (2017) · Clinical Toxicology · doi:10.1080/15563650.2017.1416124 · Cited by 47
Not your regular high: cardiac dysrhythmias caused by loperamide
Wightman, R., Hoffman, R. S., Howland, M. A., Rice, B. T., Biary, R., & Lugassy, D. M. (2016) · Clinical Toxicology · doi:10.3109/15563650.2016.1159310 · Cited by 46
Loperamide dependence and abuse
MacDonald, R., Heiner, J. D., Villarreal, J. A., & Strote, J. N. (2015) · BMJ Case Reports · doi:10.1136/bcr-2015-209705 · Cited by 43
Over-the-Counter Codeine—from Therapeutic Use to Dependence, and the Grey Areas in Between
Nielsen, S., & Hout, M. C. V. (2015) · Current topics in behavioral neurosciences · doi:10.1007/7854_2015_422 · Cited by 42
Loperamide Induced Life Threatening Ventricular Arrhythmia
Upadhyay, A., Bodar, V., Malekzadegan, M., Singh, S., Frumkin, W., Mangla, A., & Doshi, K. (2016) · Case Reports in Cardiology · doi:10.1155/2016/5040176 · Cited by 40
Intentional Misuse and Abuse of Loperamide: A New Look at a Drug with “Low Abuse Potential”
Borron, S. W., Watts, S. H., Tull, J., Baeza, S., Diebold, S., & Barrow, A. (2017) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2017.03.018 · Cited by 40
Is There a Potential of Misuse for Venlafaxine and Bupropion?
Schifano, F., & Chiappini, S. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00239 · Cited by 38
Self-citationLoperamide cardiotoxicity: “A Brief Review”
Akel, T., & Bekheit, S. (2017) · Annals of Noninvasive Electrocardiology · doi:10.1111/anec.12505 · Cited by 35
Loperamide Induced Torsades de Pointes: A Case Report and Review of the Literature
Mukarram, O., Hindi, Y., Catalasan, G., & Ward, J. (2016) · Case Reports in Medicine · doi:10.1155/2016/4061980 · Cited by 32
Zaprutko, T., Koligat, D., Michalak, M., Wieczorek, M., Józiak, M., Ratajczak, M., Szydłowska, K., Miazek, J., Kus, K., & Nowakowska, E. (2016) · Health Policy · doi:10.1016/j.healthpol.2016.06.008 · Cited by 31
Notes from the Field: Cardiac Dysrhythmias After Loperamide Abuse — New York, 2008–2016
Eggleston, W. D., Marraffa, J. M., Stork, C. M., Mercurio‐Zappala, M., Su, M. K., Wightman, R., Cummings, K. R., & Schier, J. G. (2016) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6545a7 · Cited by 31
Loperamide, the “Poor Man’s Methadone”: Brief Review
Stanciu, C. N., & Gnanasegaram, S. A. (2016) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2016.1260188 · Cited by 29
Abuse of Medications That Theoretically Are Without Abuse Potential
Reeves, R. R., Ladner, M. E., Perry, C. L., Burke, R. S., & Laizer, J. T. (2015) · Southern Medical Journal · doi:10.14423/smj.0000000000000256 · Cited by 28
Drug Misuse in Adolescents Presenting to the Emergency Department
Finkelstein, Y., Goel, G., Hutson, J. R., Armstrong, J., Baum, C. R., Wax, P. M., & Brent, J. A. (2015) · Pediatric Emergency Care · doi:10.1097/pec.0000000000000571 · Cited by 28
Changes in over-the-counter drug misuse over 20 years: perceptions from Scottish pharmacists
Wright, J., Bond, C. M., Robertson, H. D., & Matheson, C. (2015) · Journal of Public Health · doi:10.1093/pubmed/fdv169 · Cited by 26
Zhang, Y., Zhou, T., Duan, J., Xiao, Z., Li, G., & Xu, F. (2013) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2013.04.012 · Cited by 25
Fox, N. J., Ward, K. J., & O’Rourke, A. (2005) · Social Science & Medicine · doi:10.1016/j.socscimed.2005.03.011 · Cited by 25
Le, V. T., Turner, A. N., McDaniel, A. E., Hale, K. M., Athas, C., & Kwiek, N. C. (2017) · Journal of American College Health · doi:10.1080/07448481.2017.1356312 · Cited by 23
VAUGHN, P., Solik, M., Bagga, S., & Padanilam, B. J. (2016) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.13052 · Cited by 22
Loperamide metabolite-induced cardiomyopathy and QTc prolongation
Bhatti, Z., Norsworthy, J., & Szombathy, T. (2017) · Clinical Toxicology · doi:10.1080/15563650.2017.1304555 · Cited by 19
Torsades de pointes with high-dose loperamide
Kozák, P., Harris, A. J., McPherson, J., & Roden, D. M. (2017) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2017.01.011 · Cited by 13
Cardiac Dysrhythmias Associated With Substitutive Use of Loperamide: A Systematic Review
Riaz, I. B., Khan, M. S., Kamal, M. U., Sipra, Q.-U.-A. R., Riaz, A., Zahid, U., & Bhattacharjee, S. (2017) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000000585 · Cited by 11
Methadone Management of Withdrawal Associated With Loperamide-related Opioid Use Disorder
Leo, R. J., Ghazi, M. A., & Jaziri, K. S. (2017) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000325 · Cited by 10
ERRATUM: Unexpected Serious Cardiac Arrhythmias in the Setting of Loperamide Abuse.
Rasla, S., Parikh, P., Hoffmeister, P. S., Amand, A. S., Garas, M., Meligy, A. E., Minami, T., & Shah, N. R. (2017) · PubMed · Cited by 10
Selbstmedikation, Gesundheit und Internetbestellung: Eine Online-Befragung
Eichenberg, C., & Hübner, L. (2015) · Das Gesundheitswesen · doi:10.1055/s-0035-1549970 · Cited by 7
Loperamide-related deaths in North Carolina
Ruan, X., Luo, J. J., & Kaye, A. D. (2016) · Medico-Legal Journal · doi:10.1177/0025817216672116 · Cited by 6
High doses of loperamide can cause serious cardiac events
Rose, B. J. (2016) · Pharmacy Today · doi:10.1016/j.ptdy.2016.06.021 · Cited by 1
Serebruany, V. L., & Kim, M. H. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy565.2230 · Cited by 1
Cited by
Cardiovascular Complications of Opioid Use
Krantz, M. J., Palmer, R. B., & Haigney, M. C. P. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.002 · Cited by 158
New/emerging psychoactive substances and associated psychopathological consequences
Schifano, F., Napoletano, F., Chiappini, S., Guirguis, A., Corkery, J. M., Bonaccorso, S., Ricciardi, A., Scherbaum, N., & Vento, A. (2021) · Psychological Medicine · doi:10.1017/s0033291719001727 · Cited by 119
“Cytochrome inhibitors, such as cimetidine, omeprazole and grapefruit juice, as well as P-glycoprotein inhibitors, such as quinidine-quinine and pepper, may be concomitantly used to raise the drug blood levels (Baker, 2007; Schifano and Chiappini, 2018b) (Table 1).”
BackgroundSelf-citationSex and Gender Differences in the Effects of Novel Psychoactive Substances
Fattore, L., Marti, M., Mostallino, R., & Castelli, M. P. (2020) · Brain Sciences · doi:10.3390/brainsci10090606 · Cited by 78
Schifano, F., Chiappini, S., Corkery, J. M., & Guirguis, A. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00046 · Cited by 55
Self-citationAlgarni, M., Hadi, M. A., Yahyouche, A., Mahmood, S., & Jalal, Z. (2021) · Journal of Pharmaceutical Policy and Practice · doi:10.1186/s40545-021-00350-7 · Cited by 67
“Schifano F, Chiappini S.”
BackgroundMethodInfluential
Metadata
- Authors
- Schifano, F., & Chiappini, S.
- Affiliations
- University of Hertfordshire (GB)
- Corresponding author
- Chiappini, Stefania
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2018-10-04
- Volume
- 13
- Issue
- 10
- Pages
- e0204443
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC6171858
- OpenAlex
- W2895091112
- Cited by
- 44
- References
- 52
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 5 · 2023: 5 · 2022: 5 · 2021: 10 · 2020: 8 · 2019: 8
- FWCI
- 5.44
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Health Sciences › Medicine › Emergency Medicine › Poisoning and overdose treatments
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- loperamide, drug abuse, drug addiction, withdrawal, cardiotoxicity, adverse drug reactions, over-the-counter drugs, EudraVigilance, pharmacovigilance, intentional overdose, drug use disorders, polydrug use, cardiovascular adverse events, electrocardiographic abnormalities
- MeSH terms
- Drug Misuse, Adolescent, Adult, Cardiovascular Diseases, Nonprescription Drugs, Europe, Female, Humans, Loperamide, Male, Middle Aged, Polypharmacy, Substance-Related Disorders, Young Adult, Pharmacovigilance, Databases, Pharmaceutical
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.